Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 233

3.

Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast.

Honma N, Takubo K, Akiyama F, Sawabe M, Arai T, Younes M, Kasumi F, Sakamoto G.

Histopathology. 2005 Aug;47(2):195-201.

PMID:
16045781
5.

Cell turnover in apocrine metaplasia and apocrine adenosis of the breast.

Elayat G, Selim AG, Wells CA.

Ann Diagn Pathol. 2010 Feb;14(1):1-7. doi: 10.1016/j.anndiagpath.2009.05.001.

PMID:
20123450
6.
7.

Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.

Sapino A, Righi L, Cassoni P, Papotti M, Gugliotta P, Bussolati G.

Mod Pathol. 2001 Aug;14(8):768-76.

8.
9.

Apocrine metaplasia of breast cancer: clinicopathological features and predicting response.

Ogiya A, Horii R, Osako T, Ito Y, Iwase T, Eishi Y, Akiyama F.

Breast Cancer. 2010 Oct;17(4):290-7. doi: 10.1007/s12282-009-0178-9. Epub 2009 Sep 30.

PMID:
19789945
10.

Extramammary Paget disease is characterized by the consistent lack of estrogen and progesterone receptors but frequently expresses androgen receptor.

Diaz de Leon E, Carcangiu ML, Prieto VG, McCue PA, Burchette JL, To G, Norris BA, Kovatich AJ, Sanchez RL, Krigman HR, Gatalica Z.

Am J Clin Pathol. 2000 Apr;113(4):572-5.

PMID:
10761460
11.

Apocrine epithelium of the breast: does it result from metaplasia?

Viacava P, Naccarato AG, Bevilacqua G.

Virchows Arch. 1997 Sep;431(3):205-9.

PMID:
9334842
12.

Expression of androgen receptors and inhibin/activin alpha and betaA subunits in breast apocrine lesions.

Shim HS, Jung WH, Kim H, Park K, Cho NH.

APMIS. 2006 May;114(5):352-8.

PMID:
16725011
13.

An immunohistochemical study of androgen, oestrogen and progesterone receptors in the vulva and vagina.

Hodgins MB, Spike RC, Mackie RM, MacLean AB.

Br J Obstet Gynaecol. 1998 Feb;105(2):216-22.

PMID:
9501790
14.

Expression of oestrogen receptor-beta in apocrine carcinomas of the breast.

Honma N, Takubo K, Akiyama F, Kasumi F, Sawabe M, Arai T, Hosoi T, Yoshimura N, Harada N, Younes M, Sakamoto G.

Histopathology. 2007 Mar;50(4):425-33.

PMID:
17448017
15.

Histological and immunohistochemical analysis of apocrine breast carcinoma.

Matsuo K, Fukutomi T, Hasegawa T, Akashi-Tanaka S, Nanasawa T, Tsuda H.

Breast Cancer. 2002;9(1):43-9.

PMID:
12196721
16.
17.

Identification of molecular apocrine breast tumours by microarray analysis.

Farmer P, Bonnefoi H, Becette V, Tubiana-Hulin M, Fumoleau P, Larsimont D, Macgrogan G, Bergh J, Cameron D, Goldstein D, Duss S, Nicoulaz AL, Brisken C, Fiche M, Delorenzi M, Iggo R.

Oncogene. 2005 Jul 7;24(29):4660-71.

PMID:
15897907
19.

Immunohistochemical analysis of steroid hormone receptors in hidradenitis suppurativa.

Buimer MG, Wobbes T, Klinkenbijl JH, Reijnen MM, Blokx WA.

Am J Dermatopathol. 2015 Feb;37(2):129-32. doi: 10.1097/DAD.0000000000000206.

PMID:
25229569
20.

Immunohistochemical analysis of estrogen and progesterone receptors in benign breast diseases.

Tóth J, De Sombre ER, Greene GL.

Zentralbl Pathol. 1991;137(3):227-32.

PMID:
1931896

Supplemental Content

Support Center